First human tests begin for west nile shot
NCT ID NCT06745921
Summary
This is an early-stage safety study for a new vaccine designed to prevent West Nile virus infection, which is spread by mosquitoes. The main goal is to check if the vaccine is safe and if it triggers an immune response in 30 healthy adults aged 18-49. Participants will receive either the vaccine or a placebo in two different dose levels to find the safest and most effective amount.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for WEST NILE VIRAL INFECTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Saint Louis University Center for Vaccine Development
St Louis, Missouri, 63104-1015, United States
Conditions
Explore the condition pages connected to this study.